Keep the shot. Cover the side it does not. An honest answer guide from Optimum.
In a randomized placebo-controlled trial (Hansen 2024), semaglutide reduced bone density at the hip and spine, with the bone-breakdown marker rising and the rebuild marker staying flat. The Wegovy label reports more hip and pelvis fractures in women on the drug than on placebo (1.0% versus 0.2%). This is an effect of fast weight loss, not a reason to stop the medication.
About a quarter of all weight lost on these drugs is lean tissue, muscle and bone, not fat, measured in kilograms (the trials measured roughly 5.6 kg and about 9.7% lean loss). In postmenopausal women, the faster the loss, the more comes out of the hip. Population fracture epidemiology is still mixed and being investigated. The point is not to quit, it is that the bone side has no protein answer.
You do not have to quit the shot to protect your bones. Protein and lifting protect muscle, they do nothing for bone, because bone does not rebuild off a plate you cannot finish. Bone rebuilds off a signal, estrogen signaling, that goes quiet at menopause. Restoring that signal is the missing layer, and it works alongside the medication.
The double hit, menopause turned the rebuild signal down, and the fast loss draws down an already-low bone reserve while appetite suppression collapses mineral intake. The protein-and-lifting shield only ever covered the muscle half. Search any protein guide for the word bone, it is not there.
For muscle, adequate protein plus resistance training is the standard, though hard on a suppressed appetite. For bone, the missing lever is the estrogen signal that tells bone to rebuild. Optimum Shilajit's fulvic acid restores that signaling without being a hormone, and carries calcium and trace minerals into bone. It works on the bone side, not the appetite side.
Shilajit works on a different system than GLP-1 drugs. The shot acts on appetite, shilajit acts on the bone-rebuild signal and mineral delivery. It is spaced about two hours from other pills. Across every human study of shilajit, zero serious adverse events have ever been reported.
Many GLP-1 users already stack creatine, magnesium, and D3 alongside the shot. This adds the one thing none of those touch, the bone-rebuild signal. Not medical advice, spacing and stacking questions are common.
Bone is living tissue that rebuilds when it gets the estrogen rebuild signal. In a placebo-controlled trial of postmenopausal women with low bone density (Pingali 2022), every single woman in the treatment group reversed her osteopenia within 24 weeks while the placebo group worsened.
Shilajit is not a hormone and does not raise estrogen. When tested on the ER-positive breast cancer cells that feed on estrogen (the MCF-7 line), fulvic acid killed the cancer cells and spared healthy cells.